The FVIII activities in various concentrations of FVIII plasma without emicizumab or plasma from a hemophilia A patient treated without emicizumab were similar between FVIII assays using the 2nd DPT of the CWA-APTT or peak heights of CWA with low TT. The gene discussed is F8; the disease is hemophilia A.